Manufacturing

Ray Successfully Concludes 5D ClearBoneCT Symposium in China

AI-Based Next-Generation Imaging Diagnostic Solution Unveiled Full-Scale Push into the Premium Digital Dentistry Market

[Edaily Reporter Shin Min-jun] Digital dentistry specialist #RAY successfully concluded its 5D ClearBoneCT Symposium.
RAY held the 5D ClearBoneCT Symposium in Beijing, China, on the 9th and provided an overview of the product. (Image: RAY)

RAY held the 5D ClearBoneCT Symposium in Beijing, China, on the 9th (local time). Approximately 200 dentists from across China attended the event. Representatives from CC Dental and Sinopharm, major Chinese distributors of dental medical equipment, were also present, demonstrating high interest.

Through this symposium, Ray introduced 5D ClearBoneCT, its next-generation imaging diagnostic solution. Based on AI technology, 5D ClearBoneCT has dramatically increased the utility of diagnostic images. It is designed to provide intuitive visual materials during patient consultations, thereby improving treatment comprehension and consent rates while maximizing the convenience of diagnosis and treatment planning.

In particular, attendees expressed great interest in the system’s ability to improve clinical efficiency and strengthen communication with patients through AI-based automatic analysis features and digital workflows.

In the Chinese dental medical device market, where price competition is intensifying, Ray is pursuing a premium strategy based on technological capabilities and clinical value rather than simple price competition. Ray plans to target high-value-added markets and secure profitability through its differentiated AI technology and digital dental solutions.

Lee Sang-cheol, CEO of Ray, stated, “While the Chinese market is one of the world’s largest dental markets, it is also a market where price-based competition is extremely fierce.” He added, “Ray will lead the premium market through innovative AI-based imaging diagnostic technology and differentiated digital dentistry solutions.”

Meanwhile, Ray is continuously improving its business structure to strengthen its competitiveness and enhance operational efficiency in the Chinese market. Last year, Ray consolidated its Shanghai branch into its Beijing headquarters to improve the financial structure of its Chinese subsidiary and streamline operations. This year, Ray is also pursuing measures to increase organizational efficiency in line with its business strategy focused on the premium market.

Going forward, Ray is further strengthening its push into the Chinese premium market, centered on the 5D ClearBoneCT. Ray plans to continuously expand its presence in the Chinese digital dentistry market by expanding cooperation with key distribution partners.

Economy

Corporation

IT·Science

Economy

A Semiconductor Fabless Company Founded by SK Hynix’s Youngest-Ever Executive [VC Cradle]

The biggest bottleneck for AI servers is memory. As the KV cache—where large language models (LLMs) store past computations—accumulates, the required memory capacity increases exponentially. This prob…
2026-07-04 09:00:07

Corporation

Genosco, Tax Risk?… “Lecraza Is ‘Royalty Income’; Its Value Remains Unchanged”

Concerns about “tax risks” have been raised in some quarters of the financial investment, pharmaceutical, and biotech markets regarding Genosco, a subsidiary of OSCOTEC Inc.(039200)specializing in new…
2026-07-04 08:31:02

IT·Science

Celltrion Pharm Inc. Builds a Plant, AriBio Secures Investment… K-Bio in ‘Expansion Mode’ [Weekly Bio Roundup]

As July began (June 29–July 3), the pharmaceutical and biotech industries turned their attention to Celltrion Pharm Inc.’s large-scale investment in production facilities and AriBio’s successful fundr…
2026-07-04 09:01:02